Exelon

rivastigmine · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Exelon, covering 2007-07-31 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Rivastigmine for the Treatment of Hypoactive Anticholinergic Delirium and CNS Depression Associated Mainly With Clozapine Poisoning. [Phase 4]

See pricing